Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications.

× No keyword cloud information.

3 in total

1. Bioanalytical method validation--a revisit with a decade of progress.

Authors: V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal: Pharm Res Date: 2000-12 Impact factor: 4.200

2. Safety of voriconazole in a patient with CYP2C92/CYP2C92 genotype.

Authors: Marcus J P Geist; Gerlinde Egerer; Jürgen Burhenne; Gerd Mikus
Journal: Antimicrob Agents Chemother Date: 2006-09 Impact factor: 5.191

3. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.

Authors: R Hyland; B C Jones; D A Smith
Journal: Drug Metab Dispos Date: 2003-05 Impact factor: 3.922

3 in total

13 in total

1. Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.

Authors: Seong Mi Moon; Hye Yun Park; Byeong-Ho Jeong; Kyeongman Jeon; Soo-Youn Lee; Won-Jung Koh
Journal: Antimicrob Agents Chemother Date: 2014-10-13 Impact factor: 5.191

Review 2. Current concepts in antifungal pharmacology.

Authors: Russell E Lewis
Journal: Mayo Clin Proc Date: 2011-08 Impact factor: 7.616

3. Effects of CYP3A4 polymorphisms on the plasma concentration of voriconazole.

Authors: H-R He; J-Y Sun; X-D Ren; T-T Wang; Y-J Zhai; S-Y Chen; Y-L Dong; J Lu
Journal: Eur J Clin Microbiol Infect Dis Date: 2014-12-17 Impact factor: 3.267

4. Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.

Authors: Sheena Mukkada; Jeannette Kirby; Nopporn Apiwattanakul; Randall T Hayden; Miguela A Caniza
Journal: Curr Clin Microbiol Rep Date: 2016-04-18

Review 5. Rifampin combination therapy for nonmycobacterial infections.

Authors: Graeme N Forrest; Kimberly Tamura
Journal: Clin Microbiol Rev Date: 2010-01 Impact factor: 26.132

6. Update on the optimal use of voriconazole for invasive fungal infections.

Authors: Asma Lat; George R Thompson
Journal: Infect Drug Resist Date: 2011-02-03 Impact factor: 4.003

7. Voriconazole pharmacokinetics in liver transplant recipients.

Authors: H J Johnson; Kelong Han; B Capitano; D Blisard; S Husain; P K Linden; A Marcos; E J Kwak; B Potoski; D L Paterson; M Romkes; R Venkataramanan
Journal: Antimicrob Agents Chemother Date: 2009-11-23 Impact factor: 5.191

8. Multidrug resistant tuberculosis co-existing with aspergilloma and invasive aspergillosis in a 50 year old diabetic woman: a case report.

Authors: Anita A Kumar; Ghanshyam Palamaner Subash Shantha; Vijay Jeyachandran; K Rajkumar; Senthilkumar Natesan; Devasena Srinivasan; Leena Dennis Joseph; Manjunath Sundaresan; Deepan Rajamanickam
Journal: Cases J Date: 2008-11-08

9. Haemoptysis in a female with diabetes mellitus: a unique presentation of chronic pulmonary aspergillosis, pulmonary tuberculosis, and Klebsiella peumoniae co-infection.

Authors: Chinonso Ekwueme; Akaninyene Asuquo Otu; Sunny Chinenye; Chioma Unachukwu; Reginald N Oputa; Ibitrokoemi Korubo; Ofem E Enang
Journal: Clin Case Rep Date: 2016-03-17

10. Phenytoin and Rifampin Do Not Decrease Levels in Acute Tacrolimus Toxicity.

Authors: Benjamin O Lawson; Heemesh Seth; Dan Quan
Journal: J Investig Med High Impact Case Rep Date: 2018-03-24